0.85% -0.0599

Kamada Ltd (KMDA)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Kamada Ltd Stock (KMDA) Company Profile

Healthcare (1131)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

KMDA's Discussions on Twitter

Vergleichen Sie KMDA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KMDA Kamada Ltd	7.02	407.23M	154.57M	15.07M	10.92M	0.27
ZTS Zoetis Inc	125.28	55.45B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.60	49.25B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.00	45.02B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	30.95	35.81B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	481.73	20.98B	3.08B	1.24B	1.07B	25.61

Kamada Ltd Stock (KMDA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-21	Eingeleitet	The Benchmark Company	Buy
2024-07-03	Eingeleitet	Stifel	Buy
2018-02-02	Eingeleitet	Chardan Capital Markets	Buy

Kamada Ltd Aktie (KMDA) Neueste Nachrichten

Finanzdaten der Kamada Ltd-Aktie (KMDA)

Kamada Ltd (KMDA)

Kamada Ltd Stock (KMDA) Company Profile

Vergleichen Sie KMDA mit anderen Aktien

Kamada Ltd Stock (KMDA) Upgrades & Downgrades

Kamada Ltd Aktie (KMDA) Neueste Nachrichten

Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World

Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN

Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga

Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com

Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда

Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда

Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда

Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber

Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks

Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда

Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда

Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria

Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com

Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com

Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks

Kamada secures $10-14 million Canadian supply tender extension - Investing.com

Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire

Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation - MSN

Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN

Breakout Zone: How geopolitical tensions affect Kamada Ltd stock2025 Earnings Surprises & Consistent Return Investment Signals - moha.gov.vn

Precision Trading with Kamada Ltd. (KMDA) Risk Zones - Stock Traders Daily

Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World

FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World

What is HC Wainwright's Forecast for Kamada FY2025 Earnings? - MarketBeat

Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World

HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World

Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks

Sidoti Csr Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus By Investing.com - Investing.com South Africa

Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga

Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com

Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks

Kamada reiterates FY25 revenue guidance $178M-$182M - TipRanks

Kamada Discontinues Phase 3 Inhaled AAT Trial, Projects Growth in 2026 - TipRanks

Kamada (KMDA) Halts Phase 3 Trial of Inhaled AAT for Alpha-1 Ant - GuruFocus

Kamada reiterates 2025 FY revenue guidance of $178M-$182M - marketscreener.com

Kamada Reiterates 2025 FY Revenue Guidance Of $178M-$182M - TradingView

Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial By Investing.com - Investing.com Canada

Kamada stock tumbles after discontinuing Phase 3 Inhaled AAT trial - Investing.com

Kamada (NASDAQ: KMDA) drops inhaled AAT study, reaffirms $178M-$182M 2025 revenue - Stock Titan

Shareholders May Not Be So Generous With Kamada Ltd.'s (TLV:KMDA) CEO Compensation And Here's Why - simplywall.st

Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat

Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average – Time to Sell? - Defense World

Technical Reactions to KMDA Trends in Macro Strategies - news.stocktradersdaily.com

Kamada updates proxy statement ahead of annual shareholder meeting By Investing.com - Investing.com Australia

Kamada updates proxy statement ahead of annual shareholder meeting - Investing.com

Finanzdaten der Kamada Ltd-Aktie (KMDA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie KMDA